ABSTRACT
OBJECTIVE: To construct the point mutants of α3* nicotine acetylcholine receptors (nAChRs), optimize the method of receptor mutagenesis and investigate the function of the mutants by using the agonist acetycholine (Ach). METHODS: The α3* nAChRs mutants were constructed by PCR mediated site-directed mutation techniques. Point mutated primers were designed according to rat α3 subunit gene. The cRNA of α3 subunit point mutant was synthesized by in vitro transcription. The expression of mutants in Xenopus oocytes were detected by two-electrode voltage-clamp techniques. Gating properties of the two mutants were detected by Ach. RESULTS: Mutants of α3β2 and α3β4 nAChRs subtypes were constructed successfully. The half effective concentrations (EC50) of wild types α3β2 and α3β4 nAChRs were 55.33 and 163.00 μmol·L-1, respectively. While the EC50 of α3(S147T)β2 and α3(S147T)β4 nAChRs mutants were 33.10 and 121.10 μmol·L-1, respectively. CONCLUSION: The construction of mutation from the 147th serine to threonine of α3 subunit can provide a function model to make more other receptor mutants, and would be helpful to interrogate the interaction between drug and α3* nAChR.